Conditions: Schizophrenia
Keywords: Schizophrenia Latuda Lurasidone
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 356
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy of the drug SM-13496 compared to a placebo and to haloperidol in patients with schizophrenia.

Detailed description:

Arms:
arm 1: Lurasidone 20 mg tablets arm 2: Lurasidone 40 mg tablets arm 3: Lurasidone 2 40 mg tablets arm 4: Haloperidol 10mg tablets arm 5: Matching Placebo to Lurasidone and Haloperidol

Interventions: intervention 1: Lurasidone 20 mg intervention 2: Lurasidone 40mg intervention 3: Lurasidone 80 mg intervention 4: Haloperidol 10mg intervention 5: Placebo
Intervention descriptions: intervention 1: Lurasidone 20mg/day tablets intervention 2: Lurasidone 40mg/day tablets intervention 3: Lurasidone 80mg/day - 2 40mg tablets intervention 4: Haloperidol 10mg/day tablets intervention 5: Matching Placebo to Lurasdione and Haloperidol

Protocol document: